Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Spotify Technology S.A. SPOT |
T. Rowe Price Associates, Inc. | 9,701,409 5.000% |
-6,401,472 (-39.75%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Equitable Holdings, Inc. EQH |
T. Rowe Price Associates, Inc. | 32,669,066 8.800% |
-12,364,589 (-27.46%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
T. Rowe Price Associates, Inc. | 7,672,398 14.700% |
2,409,797 (+45.79%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | i3 Verticals, Inc. IIIV |
T. Rowe Price Associates, Inc. | 3,840 0.000% |
-1,550,810 (-99.75%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Elanco Animal Health Incorporated ELAN |
T. Rowe Price Associates, Inc. | 18,846,927 4.000% |
-15,827,381 (-45.65%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | PennyMac Financial Services, Inc. PFSI |
T. Rowe Price Associates, Inc. | 150,248 0.300% |
-3,766,653 (-96.16%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Cigna Corporation CI |
T. Rowe Price Associates, Inc. | 13,656,608 4.500% |
-4,304,724 (-23.97%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Datadog, Inc. DDOG |
T. Rowe Price Associates, Inc. | 9,985,810 3.400% |
-5,449,460 (-35.31%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Generation Bio Co. GBIO |
T. Rowe Price Associates, Inc. | 7,261,046 12.200% |
-1,386,075 (-16.03%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | UiPath Inc. PATH |
T. Rowe Price Associates, Inc. | 3,703,850 0.800% |
-31,887,639 (-89.59%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Arco Platform Limited ARCE |
T. Rowe Price Associates, Inc. | 2,257,627 7.700% |
356,097 (+18.73%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Zoom Video Communications, Inc. ZM |
T. Rowe Price Associates, Inc. | 2,050,503 0.800% |
-16,372,059 (-88.87%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Avantor, Inc. AVTR |
T. Rowe Price Associates, Inc. | 38,913,266 5.800% |
-5,007,327 (-11.40%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Clarivate Plc CLVT |
T. Rowe Price Associates, Inc. | 182,088 0.000% |
-43,931,478 (-99.59%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
T. Rowe Price Associates, Inc. | 2,401,037 5.100% |
2,401,037 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Karuna Therapeutics, Inc. KRTX |
T. Rowe Price Associates, Inc. | 2,363,304 6.900% |
407,938 (+20.86%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | ONE Gas, Inc. OGS |
T. Rowe Price Associates, Inc. | 64,340 0.100% |
-3,096,264 (-97.96%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Paylocity Holding Corporation PCTY |
T. Rowe Price Associates, Inc. | 5,780,587 10.400% |
-2,119,684 (-26.83%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Nevro Corp. NVRO |
T. Rowe Price Associates, Inc. | 280,434 0.700% |
-2,048,097 (-87.96%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Sweetgreen, Inc. SG |
T. Rowe Price Associates, Inc. | 7,436,584 7.600% |
-3,169,321 (-29.88%) |
Filing History |